Algorae Pharmaceuticals Limited
1AI
Rang în acțiuni
#30946
Algorae Pharmaceuticals Limited, a company established in 1987 and based in... Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease. Another key candidate is AI-168, a unique blend of a cannabinoid and an existing, off-patent drug component, aimed at managing cardiovascular conditions like hypertension. Additionally, Algorae is progressing with NTCELL, an alginate-encapsulated product for the treatment of Parkinson's disease. The company is also collaborating with the University of New South Wales to create AlgaraeOS, an advanced drug discovery platform that utilizes artificial intelligence protocols and extensive data analytics to optimize drug identification and development processes.
Preț acțiune
$0.00705285
Capitalizare de piață
$14.30M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
-30.71%
Țară
AU
Tranzacționează Algorae Pharmaceuticals Limited (1AI)
Categorie
Healthcare
Capitalizarea de piață a Algorae Pharmaceuticals Limited(1AI)
Capitalizare de piață: $14.30M
În anul October 2026, Algorae Pharmaceuticals Limited are o capitalizare de piață de $14.30M. Acest lucru face ca Algorae Pharmaceuticals Limited să fie a 30946th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Algorae Pharmaceuticals Limited din 2004 până în 2026
1AI în comparație cu top 5 cele mai populare stocks
